HF Advisory Group LLC Raises Stock Holdings in Cencora, Inc. $COR

HF Advisory Group LLC grew its stake in shares of Cencora, Inc. (NYSE:COR) by 2,346.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,710 shares of the company’s stock after acquiring an additional 58,228 shares during the period. Cencora comprises approximately 0.8% of HF Advisory Group LLC’s holdings, making the stock its 20th biggest position. HF Advisory Group LLC’s holdings in Cencora were worth $20,505,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. United Bank lifted its position in Cencora by 4.5% in the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Cencora by 8.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 15,861 shares of the company’s stock valued at $4,756,000 after buying an additional 1,184 shares during the period. Quadrature Capital Ltd bought a new position in shares of Cencora during the 2nd quarter valued at about $241,000. Lido Advisors LLC boosted its holdings in Cencora by 23.0% during the second quarter. Lido Advisors LLC now owns 7,956 shares of the company’s stock worth $2,386,000 after buying an additional 1,487 shares in the last quarter. Finally, Edgestream Partners L.P. grew its holdings in shares of Cencora by 1,348.2% in the 2nd quarter. Edgestream Partners L.P. now owns 12,237 shares of the company’s stock worth $3,669,000 after acquiring an additional 11,392 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

COR has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded shares of Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Robert W. Baird set a $415.00 price target on shares of Cencora in a report on Tuesday, January 13th. Barclays upped their price objective on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Finally, Wells Fargo & Company upped their price objective on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $403.17.

Cencora Price Performance

COR opened at $318.05 on Thursday. Cencora, Inc. has a 12 month low of $267.40 and a 12 month high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The stock has a market cap of $61.87 billion, a P/E ratio of 38.23, a P/E/G ratio of 1.46 and a beta of 0.72. The company has a fifty day simple moving average of $349.74 and a 200 day simple moving average of $341.09.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. During the same quarter in the prior year, the firm earned $3.73 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year. On average, research analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio is 28.85%.

Insider Activity

In other news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the sale, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.38% of the company’s stock.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.